The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Mupirocin is applicable to the skin soft tissue infection caused by kelan positive coccus, such as pustules, furuncle, hair folliculitis and eczema, dermatitis, ulcer, trauma and other skin diseases secondary infection.
The global Mupirocin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Mupirocin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mupirocin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Mupirocin include GSK, Medimetriks Pharmaceuticals, Cardinal Health, Ortho-McNeil Pharmaceutical, Glenmark Pharmaceuticals, Taro Pharmaceuticals, BIOMES PHARMACEUTICALS, H.J. Harkins Company and Directrx, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mupirocin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mupirocin.
Report Scope
The Mupirocin market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mupirocin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mupirocin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Medimetriks Pharmaceuticals
Cardinal Health
Ortho-McNeil Pharmaceutical
Glenmark Pharmaceuticals
Taro Pharmaceuticals
BIOMES PHARMACEUTICALS
H.J. Harkins Company
Directrx
Teva Pharmaceuticals
Fougera Pharmaceuticals
Profcient
Remedy Repack
Lohxa
Nucare Pharmaceuticals
Sino-american Tianjin Shike Pharmaceutical
Hangzhou Zhuyangxin Pharmaceutical
Hubei Renfu Chengtian Pharmaceutical
Hong Kong Aomei Pharmaceutical
Segment by Type
Cream
Ointment
Other
Segment by Application
Primary Infection
Secondary Infection
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mupirocin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mupirocin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Mupirocin is applicable to the skin soft tissue infection caused by kelan positive coccus, such as pustules, furuncle, hair folliculitis and eczema, dermatitis, ulcer, trauma and other skin diseases secondary infection.
The global Mupirocin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Mupirocin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mupirocin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Mupirocin include GSK, Medimetriks Pharmaceuticals, Cardinal Health, Ortho-McNeil Pharmaceutical, Glenmark Pharmaceuticals, Taro Pharmaceuticals, BIOMES PHARMACEUTICALS, H.J. Harkins Company and Directrx, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mupirocin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mupirocin.
Report Scope
The Mupirocin market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mupirocin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mupirocin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Medimetriks Pharmaceuticals
Cardinal Health
Ortho-McNeil Pharmaceutical
Glenmark Pharmaceuticals
Taro Pharmaceuticals
BIOMES PHARMACEUTICALS
H.J. Harkins Company
Directrx
Teva Pharmaceuticals
Fougera Pharmaceuticals
Profcient
Remedy Repack
Lohxa
Nucare Pharmaceuticals
Sino-american Tianjin Shike Pharmaceutical
Hangzhou Zhuyangxin Pharmaceutical
Hubei Renfu Chengtian Pharmaceutical
Hong Kong Aomei Pharmaceutical
Segment by Type
Cream
Ointment
Other
Segment by Application
Primary Infection
Secondary Infection
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mupirocin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mupirocin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Mupirocin Market Overview
1.1 Product Overview and Scope of Mupirocin
1.2 Mupirocin Segment by Type
1.2.1 Global Mupirocin Market Value Comparison by Type (2024-2030)
1.2.2 Cream
1.2.3 Ointment
1.2.4 Other
1.3 Mupirocin Segment by Application
1.3.1 Global Mupirocin Market Value by Application: (2024-2030)
1.3.2 Primary Infection
1.3.3 Secondary Infection
1.4 Global Mupirocin Market Size Estimates and Forecasts
1.4.1 Global Mupirocin Revenue 2019-2030
1.4.2 Global Mupirocin Sales 2019-2030
1.4.3 Global Mupirocin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mupirocin Market Competition by Manufacturers
2.1 Global Mupirocin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mupirocin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mupirocin Average Price by Manufacturers (2019-2024)
2.4 Global Mupirocin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mupirocin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mupirocin, Product Type & Application
2.7 Mupirocin Market Competitive Situation and Trends
2.7.1 Mupirocin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mupirocin Players Market Share by Revenue
2.7.3 Global Mupirocin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mupirocin Retrospective Market Scenario by Region
3.1 Global Mupirocin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mupirocin Global Mupirocin Sales by Region: 2019-2030
3.2.1 Global Mupirocin Sales by Region: 2019-2024
3.2.2 Global Mupirocin Sales by Region: 2025-2030
3.3 Global Mupirocin Global Mupirocin Revenue by Region: 2019-2030
3.3.1 Global Mupirocin Revenue by Region: 2019-2024
3.3.2 Global Mupirocin Revenue by Region: 2025-2030
3.4 North America Mupirocin Market Facts & Figures by Country
3.4.1 North America Mupirocin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mupirocin Sales by Country (2019-2030)
3.4.3 North America Mupirocin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mupirocin Market Facts & Figures by Country
3.5.1 Europe Mupirocin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mupirocin Sales by Country (2019-2030)
3.5.3 Europe Mupirocin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mupirocin Market Facts & Figures by Country
3.6.1 Asia Pacific Mupirocin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mupirocin Sales by Country (2019-2030)
3.6.3 Asia Pacific Mupirocin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mupirocin Market Facts & Figures by Country
3.7.1 Latin America Mupirocin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mupirocin Sales by Country (2019-2030)
3.7.3 Latin America Mupirocin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mupirocin Market Facts & Figures by Country
3.8.1 Middle East and Africa Mupirocin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mupirocin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mupirocin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mupirocin Sales by Type (2019-2030)
4.1.1 Global Mupirocin Sales by Type (2019-2024)
4.1.2 Global Mupirocin Sales by Type (2025-2030)
4.1.3 Global Mupirocin Sales Market Share by Type (2019-2030)
4.2 Global Mupirocin Revenue by Type (2019-2030)
4.2.1 Global Mupirocin Revenue by Type (2019-2024)
4.2.2 Global Mupirocin Revenue by Type (2025-2030)
4.2.3 Global Mupirocin Revenue Market Share by Type (2019-2030)
4.3 Global Mupirocin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mupirocin Sales by Application (2019-2030)
5.1.1 Global Mupirocin Sales by Application (2019-2024)
5.1.2 Global Mupirocin Sales by Application (2025-2030)
5.1.3 Global Mupirocin Sales Market Share by Application (2019-2030)
5.2 Global Mupirocin Revenue by Application (2019-2030)
5.2.1 Global Mupirocin Revenue by Application (2019-2024)
5.2.2 Global Mupirocin Revenue by Application (2025-2030)
5.2.3 Global Mupirocin Revenue Market Share by Application (2019-2030)
5.3 Global Mupirocin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Mupirocin Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Medimetriks Pharmaceuticals
6.2.1 Medimetriks Pharmaceuticals Corporation Information
6.2.2 Medimetriks Pharmaceuticals Description and Business Overview
6.2.3 Medimetriks Pharmaceuticals Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medimetriks Pharmaceuticals Mupirocin Product Portfolio
6.2.5 Medimetriks Pharmaceuticals Recent Developments/Updates
6.3 Cardinal Health
6.3.1 Cardinal Health Corporation Information
6.3.2 Cardinal Health Description and Business Overview
6.3.3 Cardinal Health Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cardinal Health Mupirocin Product Portfolio
6.3.5 Cardinal Health Recent Developments/Updates
6.4 Ortho-McNeil Pharmaceutical
6.4.1 Ortho-McNeil Pharmaceutical Corporation Information
6.4.2 Ortho-McNeil Pharmaceutical Description and Business Overview
6.4.3 Ortho-McNeil Pharmaceutical Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ortho-McNeil Pharmaceutical Mupirocin Product Portfolio
6.4.5 Ortho-McNeil Pharmaceutical Recent Developments/Updates
6.5 Glenmark Pharmaceuticals
6.5.1 Glenmark Pharmaceuticals Corporation Information
6.5.2 Glenmark Pharmaceuticals Description and Business Overview
6.5.3 Glenmark Pharmaceuticals Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Glenmark Pharmaceuticals Mupirocin Product Portfolio
6.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.6 Taro Pharmaceuticals
6.6.1 Taro Pharmaceuticals Corporation Information
6.6.2 Taro Pharmaceuticals Description and Business Overview
6.6.3 Taro Pharmaceuticals Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Taro Pharmaceuticals Mupirocin Product Portfolio
6.6.5 Taro Pharmaceuticals Recent Developments/Updates
6.7 BIOMES PHARMACEUTICALS
6.6.1 BIOMES PHARMACEUTICALS Corporation Information
6.6.2 BIOMES PHARMACEUTICALS Description and Business Overview
6.6.3 BIOMES PHARMACEUTICALS Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BIOMES PHARMACEUTICALS Mupirocin Product Portfolio
6.7.5 BIOMES PHARMACEUTICALS Recent Developments/Updates
6.8 H.J. Harkins Company
6.8.1 H.J. Harkins Company Corporation Information
6.8.2 H.J. Harkins Company Description and Business Overview
6.8.3 H.J. Harkins Company Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 H.J. Harkins Company Mupirocin Product Portfolio
6.8.5 H.J. Harkins Company Recent Developments/Updates
6.9 Directrx
6.9.1 Directrx Corporation Information
6.9.2 Directrx Description and Business Overview
6.9.3 Directrx Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Directrx Mupirocin Product Portfolio
6.9.5 Directrx Recent Developments/Updates
6.10 Teva Pharmaceuticals
6.10.1 Teva Pharmaceuticals Corporation Information
6.10.2 Teva Pharmaceuticals Description and Business Overview
6.10.3 Teva Pharmaceuticals Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Teva Pharmaceuticals Mupirocin Product Portfolio
6.10.5 Teva Pharmaceuticals Recent Developments/Updates
6.11 Fougera Pharmaceuticals
6.11.1 Fougera Pharmaceuticals Corporation Information
6.11.2 Fougera Pharmaceuticals Mupirocin Description and Business Overview
6.11.3 Fougera Pharmaceuticals Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Fougera Pharmaceuticals Mupirocin Product Portfolio
6.11.5 Fougera Pharmaceuticals Recent Developments/Updates
6.12 Profcient
6.12.1 Profcient Corporation Information
6.12.2 Profcient Mupirocin Description and Business Overview
6.12.3 Profcient Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Profcient Mupirocin Product Portfolio
6.12.5 Profcient Recent Developments/Updates
6.13 Remedy Repack
6.13.1 Remedy Repack Corporation Information
6.13.2 Remedy Repack Mupirocin Description and Business Overview
6.13.3 Remedy Repack Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Remedy Repack Mupirocin Product Portfolio
6.13.5 Remedy Repack Recent Developments/Updates
6.14 Lohxa
6.14.1 Lohxa Corporation Information
6.14.2 Lohxa Mupirocin Description and Business Overview
6.14.3 Lohxa Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lohxa Mupirocin Product Portfolio
6.14.5 Lohxa Recent Developments/Updates
6.15 Nucare Pharmaceuticals
6.15.1 Nucare Pharmaceuticals Corporation Information
6.15.2 Nucare Pharmaceuticals Mupirocin Description and Business Overview
6.15.3 Nucare Pharmaceuticals Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Nucare Pharmaceuticals Mupirocin Product Portfolio
6.15.5 Nucare Pharmaceuticals Recent Developments/Updates
6.16 Sino-american Tianjin Shike Pharmaceutical
6.16.1 Sino-american Tianjin Shike Pharmaceutical Corporation Information
6.16.2 Sino-american Tianjin Shike Pharmaceutical Mupirocin Description and Business Overview
6.16.3 Sino-american Tianjin Shike Pharmaceutical Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Sino-american Tianjin Shike Pharmaceutical Mupirocin Product Portfolio
6.16.5 Sino-american Tianjin Shike Pharmaceutical Recent Developments/Updates
6.17 Hangzhou Zhuyangxin Pharmaceutical
6.17.1 Hangzhou Zhuyangxin Pharmaceutical Corporation Information
6.17.2 Hangzhou Zhuyangxin Pharmaceutical Mupirocin Description and Business Overview
6.17.3 Hangzhou Zhuyangxin Pharmaceutical Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Hangzhou Zhuyangxin Pharmaceutical Mupirocin Product Portfolio
6.17.5 Hangzhou Zhuyangxin Pharmaceutical Recent Developments/Updates
6.18 Hubei Renfu Chengtian Pharmaceutical
6.18.1 Hubei Renfu Chengtian Pharmaceutical Corporation Information
6.18.2 Hubei Renfu Chengtian Pharmaceutical Mupirocin Description and Business Overview
6.18.3 Hubei Renfu Chengtian Pharmaceutical Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Hubei Renfu Chengtian Pharmaceutical Mupirocin Product Portfolio
6.18.5 Hubei Renfu Chengtian Pharmaceutical Recent Developments/Updates
6.19 Hong Kong Aomei Pharmaceutical
6.19.1 Hong Kong Aomei Pharmaceutical Corporation Information
6.19.2 Hong Kong Aomei Pharmaceutical Mupirocin Description and Business Overview
6.19.3 Hong Kong Aomei Pharmaceutical Mupirocin Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Hong Kong Aomei Pharmaceutical Mupirocin Product Portfolio
6.19.5 Hong Kong Aomei Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mupirocin Industry Chain Analysis
7.2 Mupirocin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mupirocin Production Mode & Process
7.4 Mupirocin Sales and Marketing
7.4.1 Mupirocin Sales Channels
7.4.2 Mupirocin Distributors
7.5 Mupirocin Customers
8 Mupirocin Market Dynamics
8.1 Mupirocin Industry Trends
8.2 Mupirocin Market Drivers
8.3 Mupirocin Market Challenges
8.4 Mupirocin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Mupirocin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Mupirocin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Mupirocin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Mupirocin Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Mupirocin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Mupirocin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Mupirocin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Mupirocin Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Mupirocin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Mupirocin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mupirocin, Product Type & Application
Table 12. Global Key Manufacturers of Mupirocin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mupirocin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mupirocin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mupirocin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Mupirocin Sales by Region (2019-2024) & (KG)
Table 18. Global Mupirocin Sales Market Share by Region (2019-2024)
Table 19. Global Mupirocin Sales by Region (2025-2030) & (KG)
Table 20. Global Mupirocin Sales Market Share by Region (2025-2030)
Table 21. Global Mupirocin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Mupirocin Revenue Market Share by Region (2019-2024)
Table 23. Global Mupirocin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Mupirocin Revenue Market Share by Region (2025-2030)
Table 25. North America Mupirocin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Mupirocin Sales by Country (2019-2024) & (KG)
Table 27. North America Mupirocin Sales by Country (2025-2030) & (KG)
Table 28. North America Mupirocin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Mupirocin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Mupirocin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Mupirocin Sales by Country (2019-2024) & (KG)
Table 32. Europe Mupirocin Sales by Country (2025-2030) & (KG)
Table 33. Europe Mupirocin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Mupirocin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Mupirocin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Mupirocin Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Mupirocin Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Mupirocin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Mupirocin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Mupirocin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Mupirocin Sales by Country (2019-2024) & (KG)
Table 42. Latin America Mupirocin Sales by Country (2025-2030) & (KG)
Table 43. Latin America Mupirocin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Mupirocin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Mupirocin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Mupirocin Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Mupirocin Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Mupirocin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Mupirocin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Mupirocin Sales (KG) by Type (2019-2024)
Table 51. Global Mupirocin Sales (KG) by Type (2025-2030)
Table 52. Global Mupirocin Sales Market Share by Type (2019-2024)
Table 53. Global Mupirocin Sales Market Share by Type (2025-2030)
Table 54. Global Mupirocin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Mupirocin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Mupirocin Revenue Market Share by Type (2019-2024)
Table 57. Global Mupirocin Revenue Market Share by Type (2025-2030)
Table 58. Global Mupirocin Price (US$/G) by Type (2019-2024)
Table 59. Global Mupirocin Price (US$/G) by Type (2025-2030)
Table 60. Global Mupirocin Sales (KG) by Application (2019-2024)
Table 61. Global Mupirocin Sales (KG) by Application (2025-2030)
Table 62. Global Mupirocin Sales Market Share by Application (2019-2024)
Table 63. Global Mupirocin Sales Market Share by Application (2025-2030)
Table 64. Global Mupirocin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Mupirocin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Mupirocin Revenue Market Share by Application (2019-2024)
Table 67. Global Mupirocin Revenue Market Share by Application (2025-2030)
Table 68. Global Mupirocin Price (US$/G) by Application (2019-2024)
Table 69. Global Mupirocin Price (US$/G) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. GSK Mupirocin Product
Table 74. GSK Recent Developments/Updates
Table 75. Medimetriks Pharmaceuticals Corporation Information
Table 76. Medimetriks Pharmaceuticals Description and Business Overview
Table 77. Medimetriks Pharmaceuticals Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. Medimetriks Pharmaceuticals Mupirocin Product
Table 79. Medimetriks Pharmaceuticals Recent Developments/Updates
Table 80. Cardinal Health Corporation Information
Table 81. Cardinal Health Description and Business Overview
Table 82. Cardinal Health Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. Cardinal Health Mupirocin Product
Table 84. Cardinal Health Recent Developments/Updates
Table 85. Ortho-McNeil Pharmaceutical Corporation Information
Table 86. Ortho-McNeil Pharmaceutical Description and Business Overview
Table 87. Ortho-McNeil Pharmaceutical Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. Ortho-McNeil Pharmaceutical Mupirocin Product
Table 89. Ortho-McNeil Pharmaceutical Recent Developments/Updates
Table 90. Glenmark Pharmaceuticals Corporation Information
Table 91. Glenmark Pharmaceuticals Description and Business Overview
Table 92. Glenmark Pharmaceuticals Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Glenmark Pharmaceuticals Mupirocin Product
Table 94. Glenmark Pharmaceuticals Recent Developments/Updates
Table 95. Taro Pharmaceuticals Corporation Information
Table 96. Taro Pharmaceuticals Description and Business Overview
Table 97. Taro Pharmaceuticals Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Taro Pharmaceuticals Mupirocin Product
Table 99. Taro Pharmaceuticals Recent Developments/Updates
Table 100. BIOMES PHARMACEUTICALS Corporation Information
Table 101. BIOMES PHARMACEUTICALS Description and Business Overview
Table 102. BIOMES PHARMACEUTICALS Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. BIOMES PHARMACEUTICALS Mupirocin Product
Table 104. BIOMES PHARMACEUTICALS Recent Developments/Updates
Table 105. H.J. Harkins Company Corporation Information
Table 106. H.J. Harkins Company Description and Business Overview
Table 107. H.J. Harkins Company Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. H.J. Harkins Company Mupirocin Product
Table 109. H.J. Harkins Company Recent Developments/Updates
Table 110. Directrx Corporation Information
Table 111. Directrx Description and Business Overview
Table 112. Directrx Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 113. Directrx Mupirocin Product
Table 114. Directrx Recent Developments/Updates
Table 115. Teva Pharmaceuticals Corporation Information
Table 116. Teva Pharmaceuticals Description and Business Overview
Table 117. Teva Pharmaceuticals Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 118. Teva Pharmaceuticals Mupirocin Product
Table 119. Teva Pharmaceuticals Recent Developments/Updates
Table 120. Fougera Pharmaceuticals Corporation Information
Table 121. Fougera Pharmaceuticals Description and Business Overview
Table 122. Fougera Pharmaceuticals Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 123. Fougera Pharmaceuticals Mupirocin Product
Table 124. Fougera Pharmaceuticals Recent Developments/Updates
Table 125. Profcient Corporation Information
Table 126. Profcient Description and Business Overview
Table 127. Profcient Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 128. Profcient Mupirocin Product
Table 129. Profcient Recent Developments/Updates
Table 130. Remedy Repack Corporation Information
Table 131. Remedy Repack Description and Business Overview
Table 132. Remedy Repack Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 133. Remedy Repack Mupirocin Product
Table 134. Remedy Repack Recent Developments/Updates
Table 135. Lohxa Corporation Information
Table 136. Lohxa Description and Business Overview
Table 137. Lohxa Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 138. Lohxa Mupirocin Product
Table 139. Lohxa Recent Developments/Updates
Table 140. Nucare Pharmaceuticals Corporation Information
Table 141. Nucare Pharmaceuticals Description and Business Overview
Table 142. Nucare Pharmaceuticals Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 143. Nucare Pharmaceuticals Mupirocin Product
Table 144. Nucare Pharmaceuticals Recent Developments/Updates
Table 145. Sino-american Tianjin Shike Pharmaceutical Corporation Information
Table 146. Sino-american Tianjin Shike Pharmaceutical Description and Business Overview
Table 147. Sino-american Tianjin Shike Pharmaceutical Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 148. Sino-american Tianjin Shike Pharmaceutical Mupirocin Product
Table 149. Sino-american Tianjin Shike Pharmaceutical Recent Developments/Updates
Table 150. Hangzhou Zhuyangxin Pharmaceutical Corporation Information
Table 151. Hangzhou Zhuyangxin Pharmaceutical Description and Business Overview
Table 152. Hangzhou Zhuyangxin Pharmaceutical Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 153. Hangzhou Zhuyangxin Pharmaceutical Mupirocin Product
Table 154. Hangzhou Zhuyangxin Pharmaceutical Recent Developments/Updates
Table 155. Hubei Renfu Chengtian Pharmaceutical Corporation Information
Table 156. Hubei Renfu Chengtian Pharmaceutical Description and Business Overview
Table 157. Hubei Renfu Chengtian Pharmaceutical Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 158. Hubei Renfu Chengtian Pharmaceutical Mupirocin Product
Table 159. Hubei Renfu Chengtian Pharmaceutical Recent Developments/Updates
Table 160. Hong Kong Aomei Pharmaceutical Corporation Information
Table 161. Hong Kong Aomei Pharmaceutical Description and Business Overview
Table 162. Hong Kong Aomei Pharmaceutical Mupirocin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 163. Hong Kong Aomei Pharmaceutical Mupirocin Product
Table 164. Hong Kong Aomei Pharmaceutical Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Mupirocin Distributors List
Table 168. Mupirocin Customers List
Table 169. Mupirocin Market Trends
Table 170. Mupirocin Market Drivers
Table 171. Mupirocin Market Challenges
Table 172. Mupirocin Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mupirocin
Figure 2. Global Mupirocin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Mupirocin Market Share by Type in 2023 & 2030
Figure 4. Cream Product Picture
Figure 5. Ointment Product Picture
Figure 6. Other Product Picture
Figure 7. Global Mupirocin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Mupirocin Market Share by Application in 2023 & 2030
Figure 9. Primary Infection
Figure 10. Secondary Infection
Figure 11. Global Mupirocin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Mupirocin Market Size (2019-2030) & (US$ Million)
Figure 13. Global Mupirocin Sales (2019-2030) & (KG)
Figure 14. Global Mupirocin Average Price (US$/G) & (2019-2030)
Figure 15. Mupirocin Report Years Considered
Figure 16. Mupirocin Sales Share by Manufacturers in 2023
Figure 17. Global Mupirocin Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Mupirocin Players: Market Share by Revenue in 2023
Figure 19. Mupirocin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Mupirocin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Mupirocin Sales Market Share by Country (2019-2030)
Figure 22. North America Mupirocin Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Mupirocin Sales Market Share by Country (2019-2030)
Figure 26. Europe Mupirocin Revenue Market Share by Country (2019-2030)
Figure 27. Germany Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Mupirocin Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Mupirocin Revenue Market Share by Region (2019-2030)
Figure 34. China Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Mupirocin Sales Market Share by Country (2019-2030)
Figure 45. Latin America Mupirocin Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Mupirocin Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Mupirocin Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Mupirocin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Mupirocin by Type (2019-2030)
Figure 55. Global Revenue Market Share of Mupirocin by Type (2019-2030)
Figure 56. Global Mupirocin Price (US$/G) by Type (2019-2030)
Figure 57. Global Sales Market Share of Mupirocin by Application (2019-2030)
Figure 58. Global Revenue Market Share of Mupirocin by Application (2019-2030)
Figure 59. Global Mupirocin Price (US$/G) by Application (2019-2030)
Figure 60. Mupirocin Value Chain
Figure 61. Mupirocin Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
